State of Wyoming Purchases 32,217 Shares of Clover Health Investments, Corp. (NASDAQ:CLOV)

State of Wyoming lifted its position in Clover Health Investments, Corp. (NASDAQ:CLOV) by 36.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 120,876 shares of the company’s stock after buying an additional 32,217 shares during the period. State of Wyoming’s holdings in Clover Health Investments were worth $381,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Clover Health Investments in the fourth quarter worth approximately $592,000. OMERS ADMINISTRATION Corp lifted its stake in shares of Clover Health Investments by 108.6% in the fourth quarter. OMERS ADMINISTRATION Corp now owns 111,600 shares of the company’s stock worth $352,000 after buying an additional 58,100 shares in the last quarter. Millennium Management LLC raised its holdings in shares of Clover Health Investments by 5,071.2% during the fourth quarter. Millennium Management LLC now owns 1,245,701 shares of the company’s stock valued at $3,924,000 after purchasing an additional 1,221,612 shares during the last quarter. Jefferies Financial Group Inc. purchased a new position in shares of Clover Health Investments during the fourth quarter valued at approximately $135,000. Finally, Graham Capital Management L.P. purchased a new position in shares of Clover Health Investments during the fourth quarter valued at approximately $889,000. Institutional investors own 19.77% of the company’s stock.

Clover Health Investments Stock Up 2.5%

CLOV opened at $3.69 on Wednesday. The firm has a 50 day moving average price of $3.56 and a 200-day moving average price of $3.68. Clover Health Investments, Corp. has a twelve month low of $0.90 and a twelve month high of $4.87. The stock has a market capitalization of $1.88 billion, a price-to-earnings ratio of -18.45 and a beta of 1.99.

Clover Health Investments (NASDAQ:CLOV) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.12. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. The firm had revenue of $462.33 million during the quarter, compared to analysts’ expectations of $466.93 million. As a group, analysts expect that Clover Health Investments, Corp. will post -0.12 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group boosted their price objective on shares of Clover Health Investments from $4.20 to $4.50 and gave the company a “buy” rating in a report on Monday, March 3rd.

Insider Buying and Selling at Clover Health Investments

In other Clover Health Investments news, General Counsel Karen Soares sold 52,500 shares of the company’s stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $3.80, for a total transaction of $199,500.00. Following the completion of the sale, the general counsel now directly owns 1,299,663 shares of the company’s stock, valued at approximately $4,938,719.40. This represents a 3.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Brady Patrick Priest sold 75,000 shares of the company’s stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $3.68, for a total transaction of $276,000.00. Following the sale, the chief executive officer now directly owns 2,418,151 shares of the company’s stock, valued at approximately $8,898,795.68. This represents a 3.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 327,500 shares of company stock valued at $1,197,500. Insiders own 22.28% of the company’s stock.

Clover Health Investments Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.